Corvus Pharmaceuticals Inc (NAS:CRVS)
$ 4.9 0.35 (7.69%) Market Cap: 314.86 Mil Enterprise Value: 273.56 Mil PE Ratio: 0 PB Ratio: 24.75 GF Score: 37/100

Corvus Pharmaceuticals Inc Annual Shareholders Meeting Transcript

Jun 09, 2020 / 08:00PM GMT
Release Date Price: $3.27 (+4.47%)
Operator

Hello, and welcome to the 2020 Annual Meeting of Stockholders of Corvus Pharmaceuticals, Inc. Please note that today's meeting is being recorded. (Operator Instructions)

It is now my pleasure to turn today's meeting over to Richard Miller, CEO and Chairman of Corvus Board of Directors. Dr. Miller, the floor is yours.

Richard A. Miller
Corvus Pharmaceuticals, Inc. - Co-Founder, President, CEO & Chairman of the Board

Thank you. Good afternoon, ladies and gentlemen. Will the meeting please come to order? I would like to welcome all of you to the Virtual Annual Meeting of Stockholders of Corvus Pharmaceuticals, Inc. I am Richard Miller, the CEO and Chairman of Corvus' Board of Directors and I will be presiding at this meeting. Also present today are members of our Board of Directors. Michelle Lu of Latham & Watkins will act as Secretary of the meeting. Leiv Lea, Corvus' CFO, has been appointed to act as inspector of election. (Operator Instructions)

The Secretary has delivered an affidavit of mailing, establishing that notice of this

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot